Cargando…

“When Treatment Is More Challenging than the Disease”: A Qualitative Study of MDR-TB Patient Retention

BACKGROUND: One-fifth of the patients on multidrug-resistant tuberculosis treatment at the Drug-Resistant-TB (DR-TB) Site in Gujarat are lost-to-follow-up(LFU). OBJECTIVE: To understand patients’ and providers' perspectives on reasons for LFU and their suggestions to improve retention-in-care....

Descripción completa

Detalles Bibliográficos
Autores principales:	Shringarpure, Kalpita S., Isaakidis, Petros, Sagili, Karuna D., Baxi, R. K., Das, Mrinalini, Daftary, Amrita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784928/ https://www.ncbi.nlm.nih.gov/pubmed/26959366 http://dx.doi.org/10.1371/journal.pone.0150849

Ejemplares similares

Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It
por: Shringarpure, Kalpita S., et al.
Publicado: (2015)

Strategies to detect and manage latent tuberculosis infection among household contacts of pulmonary TB patients in high TB burden countries ‐ a systematic review and meta‐analysis
por: Sagili, Karuna Devi, et al.
Publicado: (2022)

Patient adherence to tuberculosis treatment in the Indian subcontinent: systematic review and meta-synthesis of qualitative research
por: Shringarpure, Kalpita, et al.
Publicado: (2023)

HIV, multidrug-resistant TB and depressive symptoms: when three conditions collide
por: Das, Mrinalini, et al.
Publicado: (2014)

Cost-effectiveness of GeneXpert and LED-FM for diagnosis of pulmonary tuberculosis: A systematic review
por: Sagili, Karuna D., et al.
Publicado: (2018)

Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016–2017
por: Rathi, Priya, et al.
Publicado: (2020)

‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012)

Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study
por: Das, Mrinalini, et al.
Publicado: (2021)

In the eye of the multiple beholders: Qualitative research perspectives on studying and encouraging quality of TB care in India
por: McDowell, Andrew, et al.
Publicado: (2019)

Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India
por: Isaakidis, Petros, et al.
Publicado: (2012)

Post-primary pulmonary TB haemoptysis – When there is more than meets the eye
por: Seedat, Ubaid Feroze, et al.
Publicado: (2018)

MDR TB Transmission, Singapore
por: Chee, Cynthia B.E., et al.
Publicado: (2013)

Prevalence of menopausal symptoms among women in Vadodara, Central Gujarat: The urban-rural divide
por: Shringarpure, Kalpita S., et al.
Publicado: (2022)

“They Know, They Agree, but They Don’t Do”- The Paradox of Tuberculosis Case Notification by Private Practitioners in Alappuzha District, Kerala, India
por: Philip, Sairu, et al.
Publicado: (2015)

Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar
por: Wai, Pyae Phyo, et al.
Publicado: (2018)

Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study
por: Bieh, Kingsley Lezor, et al.
Publicado: (2017)

Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India
por: Dhakulkar, Shubhangi, et al.
Publicado: (2021)

Early implementation challenges in electronic referral and feedback mechanism for patients with tuberculosis using Nikshay – A mixed-methods study from a medical college TB referral unit of Delhi, India
por: Arora, Reema, et al.
Publicado: (2021)

“Side effects--part of the package”: a mixed methods approach to study adverse events among patients being programmatically treated for DR-TB in Gujarat, India
por: Jakasania, Arjunkumar, et al.
Publicado: (2020)

Management of MDR-TB: Review of Iran's Experience
por: Masjedi, Mohammad Reza, et al.
Publicado: (2013)

MDR-TB in Pakistan: Challenges, efforts, and recommendations
por: Khan, Mahad Ahmed, et al.
Publicado: (2022)

The START Study to evaluate the effectiveness of a combination intervention package to enhance antiretroviral therapy uptake and retention during TB treatment among TB/HIV patients in Lesotho: rationale and design of a mixed-methods, cluster-randomized trial
por: Howard, Andrea A., et al.
Publicado: (2016)

Issues in design and interpretation of MDR-TB clinical trials: report of the first Global MDR-TB Clinical Trials Landscape Meeting
por: Mitnick, Carole D, et al.
Publicado: (2015)

Fighting TB stigma: we need to apply lessons learnt from HIV activism
por: Daftary, Amrita, et al.
Publicado: (2017)

Heightened Vulnerability to MDR-TB Epidemics after Controlling Drug-Susceptible TB
por: Bishai, Jason D., et al.
Publicado: (2010)

The incidence of TB and MDR-TB in pediatrics and therapeutic options: a systematic review
por: Harichander, Sheetal, et al.
Publicado: (2022)

Treating drug-resistant tuberculosis in a low-intensity chronic conflict setting in India
por: Armstrong, Edward, et al.
Publicado: (2014)

Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
por: Mehari, Kibriti, et al.
Publicado: (2019)

Why has MDR-TB prevalence increased in Iran?
por: Heidary, Mohsen, et al.
Publicado: (2016)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
por: Ali, Monadil H., et al.
Publicado: (2019)

Fluoroquinolone preventive therapy for children exposed to MDR-TB
por: Gureva, T., et al.
Publicado: (2022)

Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2019)

“I Can Also Serve as an Inspiration”: A Qualitative Study of the TB&Me Blogging Experience and Its Role in MDR-TB Treatment
por: Horter, Shona, et al.
Publicado: (2014)

Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
por: Kundu, Debashish, et al.
Publicado: (2018)

Collaborative public–private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012–2016
por: Shelby, Peter W, et al.
Publicado: (2017)

759. Molecular Characterization and Epidemiology of Multidrug-Resistant Mycobacterium tuberculosis (MDR-TB) and Identification of Possible Cases of Local Transmission of MDR-TB in Kuwait
por: Mokaddas, Eiman, et al.
Publicado: (2018)

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?
por: Benbaba, Stella, et al.
Publicado: (2015)

Correction: The incidence of TB and MDR-TB in pediatrics and therapeutic options: a systematic review
por: Harichander, Sheetal, et al.
Publicado: (2022)

The Multi-Drug Resistant Tuberculosis Diagnosis and Treatment Cascade in Bangladesh
por: Hossain, Sarder Tanzir, et al.
Publicado: (2015)

Correction to: Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_khjt0m5c3d13hd5aaoj1a4f5lj